NeelTrivediMD

Oncology • Camden, NJ

Gastrointestinal Cancer, Hematologic Oncology

Hematologist/Oncologist at MD Anderson Cooper

Join to view full profile

Dr. Trivedi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Trivedi's full profile

Already have an account?

Office
2 Cooper Plz
Camden, NJ 08103
Phone+1 856-632-2667

Fax+1 732-790-0107

Summary

Dr. Neel Trivedi is a hematologist/oncologist in Camden, NJ specializing in gastrointestinal malignancies.

Education & Training

MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2017 - 2020
MedStar Health/Georgetown University HospitalResidency, Hematology and Medical Oncology, 2014 - 2020
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2020
University of Virginia School of MedicineClass of 2014
University of VirginiaBA, Psychology, 2006 - 2010

Certifications & Licensure

PA State Medical License 2022 - 2026
NJ State Medical License 2024 - 2025
MN State Medical License 2020 - 2022
DC State Medical License 2017 - 2020
VA State Medical License 2014 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

12 citations
A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies
Neel D. Trivedi, Samantha A Armstrong, Hongkun Wang, Marion Hartley, John F. Deeken
Cancer Medicine. 2021-02-27
16 citations
A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL.
Chaitra S. Ujjani, Hongkun Wang, Alan P Skarbnik, Neel Trivedi, Pari Ramzi
Blood Advances. 2018-04-10
Deciding the Duration of Adjuvant Chemotherapy in a Patient With Stage III Colon Cancer: When Can Less Be More?
Neel Trivedi, John L. Marshall
Oncology. 2017-12-15

Lectures

Comprehensive molecular profiling of paired patient samples of primary and metastatic (met) pancreatic ductal adenocarcinoma (PDAC).
2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Press Mentions

'Black Panther' star's death shines light on colon cancer in young peopleAugust 31st, 2020